Evome Medical Technologies Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LNDZF research report →
Price Chart
About the company
Evome Medical Technologies Inc. is a global company that conceives, produces, and markets medical equipment across the Americas and other international markets. The firm's diverse array of products is primarily focused on pain alleviation and physical restoration therapies.
- CEO
- Christopher Heath
- IPO
- 2015
- Employees
- 195
- HQ
- Shirley, NY, US
Get TickerSpark's AI analysis on LNDZF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $5.98K
- P/E
- -2.20
- PEG
- -0.02
- P/S
- 0.94
- P/B
- 0.73
- EV/EBITDA
- -5.46
- Div Yield
- 0.00%
- Gross Margin
- 32.56%
- Op Margin
- -24.30%
- Net Margin
- -23.87%
- ROE
- -44.17%
- ROIC
- -17.10%
Latest fiscal year · YoY change
- Revenue
- $62.63M+0.0%
- Gross Profit
- $22.53M+0.0%
- Op Income
- $-5,521,949
- Net Income
- $-15,602,915+0.0%
- EPS
- $-0.16+0.0%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.30
- RSI (14)
- 52
- Avg Volume
- 9.22K
No earnings-call transcripts are available for LNDZF yet.
- Free Float
- 99.7%
- Shares Outstanding
- 59.81M
- Float Shares
- 59.61M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 7, 21 | Wilks Kyle Lowell | other | 250,000 |
| Jun 10, 21 | CROSS LESLIE H | buy | 25,000 |
| Jun 9, 21 | CROSS LESLIE H | buy | 50,000 |
| May 21, 21 | Wilks Kyle Lowell | other | 0 |
| May 21, 21 | Kiernan Jane E | other | 0 |
| May 21, 21 | Kashkin Kenneth Blair | other | 0 |
| May 21, 21 | CROSS LESLIE H | other | 0 |
| May 21, 21 | Dalsin Michael Philip | other | 0 |
| May 21, 21 | GREENE ROGER S | other | 0 |
| May 21, 21 | Dalsin Michael Philip | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our LNDZF coverage
Recent articles, reports, and earnings notes.
No research on LNDZF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LNDZF report →Michael Dalsin Resigns as Chairman of the Board of Directors of Evome Medical Technologies
globenewswire.com · Apr 9
Evome Medical Technologies Provides Market Update
globenewswire.com · Mar 28
Evome Medical Technologies Appoints Michael Dalsin as Chairman of the Board of Directors; Increases Size of Board to Six
globenewswire.com · Mar 17
CLARIFICATION: Evome Medical Technologies Announces Significant Debt Restructuring
globenewswire.com · Feb 11
Evome Medical Technologies Announces Significant Debt Reduction and Restructuring
globenewswire.com · Feb 10
Evome Medical Technologies Grants Restricted Stock Units to New Chief Operating Officer
globenewswire.com · Jan 20
Evome Medical Technologies Posts Third Quarter 2024 Results, Generates $424,000 in Adjusted EBITDA on Stable Revenues, Further Reduces Debt
globenewswire.com · Nov 25
Evome Medical Technologies Announces Results From Its Annual General and Special Meeting of Shareholders
globenewswire.com · Nov 8
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.